ADAR1 Capital Management, LLC - 10%+ Owner at Grace Therapeutics, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
GRCE on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by ADAR1 Capital Management, LLC since 20 Sep 2025

Reported holdings for ADAR1 Capital Management, LLC in Grace Therapeutics, Inc.

Form 4 holding 10%+ Owner

Acasti Pharma Inc.

Security class
Class A Common Stock
Shares / value
959,571
Estimated value
Report date
28 Jun 2024
Price
Ownership
By: ADAR1 Partners

Transaction history for ADAR1 Capital Management, LLC in Grace Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .